Estimates from the most recent National Survey on Drug Use and Health (2019) indicate 19.3 million Americans aged 18 or older had a substance use disorder (SUD) in the previous year.1 Substance abuse is a serious issue, particularly for nearly 4% of adults in the U.S. who live with co-occurring mental illnesses. 1 Access, funding, misdiagnosis, lack of insight, or side-effects, among other reasons, cause some individuals to self-medicate or “treat” the symptoms of a mental illness by abusing alcohol or illicit drugs. This is particularly problematic as substance abuse can trigger or exacerbate mental health conditions. It is imperative that providers across the care continuum band together to address co-occurring disorders to ensure patients receive the treatment they need to address multiple concerns.
Policy and treatment advances may provide novel ways of advancing dual diagnosis and addiction treatment in the United States. Keep up-to-date this month with the research, field-tested best practice models, quality measurement concerns, and specialty treatment program developments for the patient population living with co-occurring disorders.
Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!
Recently, Marla Moses, FNP, PMHNP, PsychU Primary Care Provider Section Editor & Owner of Moses Mental Health, sat down with Nicole Neugebauer, Ph.D., Senior Medical Science Liaison with Otsuka Pharmaceutical Development & Commercialization, Inc. to discuss the current treatments for individuals with opioid use disorder and the challenges they have when seeking treatment. She discusses how the opioid epidemic has impacted her community and how her practice treats those individuals; primarily through the use of individualized treatments
In an effort to improve care coordination through information sharing, SAMHSA proposed rule changes to 42 CF part 2 regulations on confidentiality of health records for individuals receiving addiction treatment in late August 2019.
Of the 115 million opioid prescriptions dispensed in the U.S. each year, an estimated 60 million (51.4%) are received by adults with a mental health disorder. Approximately 19% of adults with a mental health disorder use opioids.
The way that co-occurring substance use and mental health disorders are treated can be sequential, parallel, or integrated. In contrast to the other two methodologies, integrated treatment addresses both conditions with evidence-based practices at the same time in the same treatment location.
Behavioral therapy for patients with SUD might include: integrated dual-diagnosis treatment; family behavior therapy; motivational interviewing; CBT; contingency management; or self-help and support groups.
Substance abuse among patients with serious psychiatric disorders contributes to worsened course of illness, increased relapse and rehospitalization, impaired social functioning, and housing instability.